About this trial
This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult women, aged 21-65 years old.
Do not have any medical or psychiatric condition affecting the ability to give voluntary informed consent.
Be able to read and understand English
Disqualifiers
Participants currently on menses
Inability to provide Informed Consent
Previous total hysterectomy
History of radiation treatment for cervical cancer
Trial design
Crossover
Treatments tested in this trial
Pap smear collection using the Personal Pap Smear (PPS) Device
DeviceDiagnostic Test: Use of PPS device to collect cervical cells during pap smear collection.
Active Comparator: Pap smear collection using the Rovers Cervex-Brush
DeviceDiagnostic Test: Use of Rovers Cervex-Brush to collect cervical cells during pap smear collection.
Treatment groups
Trial outcomes
Primary outcomes
Comparison of the samples for the Predicate Device versus PPS device
Data of Adequate versus Inadequate will be reported to include a positive percent agreement (PPA) defined as PPA= A/(A+C) and the negative percent agreement (NPA) defined as NPA = D/(B+D) along with their 95% confidence bounds using the Clopper-Pearson method.
Secondary outcomes
The Comparison of Cell Types of the PPS Device versus the Predicate Device
The PPS Device and the Predicate Device cell types will be measured against the 2014 Bethesda cytology categories that will be displayed in a 8 x 8 contingency table.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Morehouse School of Medicine
Lead sponsor
GyneConcepts, Inc.
Collaborator